XML 113 R77.htm IDEA: XBRL DOCUMENT v3.8.0.1
Related Party Transactions - Additional Information (Detail)
3 Months Ended 12 Months Ended
Mar. 31, 2017
USD ($)
RelatedParty
Dec. 31, 2017
USD ($)
Executive
shares
Dec. 31, 2016
USD ($)
shares
Dec. 31, 2015
USD ($)
$ / shares
shares
Dec. 31, 2014
USD ($)
$ / shares
shares
Jun. 14, 2017
shares
Related Party Transaction [Line Items]            
Stock-based compensation expense recognized   $ 14,591,000 $ 19,511,000 $ 15,527,000    
Percentage of outstanding common stock holding   5.00% 5.00%      
Convertible Bonds            
Related Party Transaction [Line Items]            
Amounts owed to related party $ 4,000,000 $ 24,000,000 $ 24,000,000      
Amount purchased in convertible bonds by holders of outstanding common stock and entity affiliate $ 2,000,000   10,000,000      
Number of related parties received convertible bonds | RelatedParty 2          
Bonds converted into shares of common stock | shares           2,727,273
Restricted Stock            
Related Party Transaction [Line Items]            
Stock-based compensation expense recognized   $ 2,160,000 8,534,000 $ 4,035,000    
Executive Officer            
Related Party Transaction [Line Items]            
Issuance of restricted stock | shares   2,520,000   1,200,000 1,320,000  
Promissory notes issued       $ 6,600,000 $ 6,000,000  
Stock Price | $ / shares       $ 5.50 $ 4.55  
Promissory note maturity term   3 years        
Stock-based compensation expense recognized   $ 0 $ 6,900,000 $ 4,000,000    
Number of executives | Executive   1        
Executive Officer | Restricted Stock            
Related Party Transaction [Line Items]            
Restricted shares vesting period   3 years        
Avalon BioMedical            
Related Party Transaction [Line Items]            
Common stock shares held by related parties | shares   678,880 678,880      
Percentage of common stock issued shares   1.17%        
Pharma Essentia            
Related Party Transaction [Line Items]            
Licenses revenue   $ 500,000 $ 0 100,000    
Taisheng            
Related Party Transaction [Line Items]            
Purchases of pharmaceutical ingredients from related party   0 200,000 100,000    
Amounts owed to related party   0 0      
ZenRx            
Related Party Transaction [Line Items]            
Licenses revenue   0 0 0    
Amounts owed to related party   100,000        
ZenRx | Clinical Development Services            
Related Party Transaction [Line Items]            
Payments to related party for services received   600,000   200,000    
ZenRx | Clinical Development Services | Maximum            
Related Party Transaction [Line Items]            
Payments to related party for services received     100,000      
RSJ Consulting LLC            
Related Party Transaction [Line Items]            
Consulting services incurred   $ 100,000 $ 200,000 $ 100,000